Sanofi and USA Pickleball launch COVID-19 education campaign
Despite their risk of serious illness from COVID-19, nearly 70% of adults 65 and older remain unvaccinated, in part due to concerns about potential side effects
Sanofi
Sanofi caps insulin costs at $35 nationwide
“No one should struggle to afford their insulin,” said Adam Gluck, Head of U.S. Corporate Affairs at Sanofi.
Sanofi completes acquisition of Blueprint Medicines
The acquisition of Blueprint brings Sanofi an established presence among allergists, dermatologists, and immunologists which is expected to enhance Sanofi’s ability to advance its growing immunology pipeline.